Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Trelleborg – page 2

453 clinical trials in Trelleborg, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Trelleborg at a glance
453
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

453 trials in Trelleborg

Open in trial search

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

An observational study of carbidopa and levodopa use with a new dispensing device and app in patients with Parkinson's disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Carbidopa
  • Sponsor:Navamedic AB

Testing inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Jazz Pharmaceuticals Ireland Limited

Prostate cancer

Recruiting

Study on Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan for Adults with Prostate Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Lutetium (177LU) vipivotide tetraxetan
  • Sponsor:Novartis Pharma AG

Study on Early Diffuse Cutaneous Systemic Sclerosis: Comparing Stem Cell Transplantation with Cyclophosphamide, Filgrastim, and Mycophenolate Mofetil

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Filgrastim
  • Sponsor:Universitair Medisch Centrum Utrecht

Phase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib Mesilate
  • Sponsor:Glaxosmithkline Research & Development Limited

Evaluation of Hydrocortisone, Octreotide, and Teres Ligament Patch Combination to Prevent Complications After Pancreatoduodenectomy in Patients with Pancreatic Head Cancer or IPMN

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Hydrocortisone
  • Sponsor:Amsterdam UMC Stichting

Study on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Unicancer

A Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Baricitinib
  • Sponsor:Eli Lilly & Co.

A Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Baricitinib
  • Sponsor:Eli Lilly & Co.

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Trelleborg

What the registry says about research in the country

01 Analytical and Diagnostic Research

Clinical trial activity in Trelleborg includes analytical and diagnostic research focused on better understanding treatment response and patient outcomes in everyday practice.

  • Assessment of symptom improvement in allergic rhinitis due to dog allergy
  • Monitoring clinical response to allergen-specific vaccination
  • Evaluation of outcome measures used to track effectiveness in routine care

These studies aim to improve how clinicians identify benefit and measure changes in patients over time.

02 Allergy and Immune System Diseases

One major focus is immune system diseases, especially allergic rhinitis due to dog allergy, with research designed to test whether targeted allergy treatment can reduce symptoms and improve quality of life.

  • Dog allergy and related nasal symptoms
  • Allergen immunotherapy in real-world Swedish practice
  • Long-term relief of allergy-related discomfort

This work explores the effectiveness of a new approach for helping patients manage persistent allergy symptoms.

03 Musculoskeletal Diseases

Another key area is musculoskeletal diseases, particularly research linked to hip arthroplasty and prevention of prosthetic joint infection.

  • Prosthetic Joint Infection after joint replacement
  • Strategies to lower infection risk following hip replacement
  • Support for safer recovery in orthopedic care

The goal is to evaluate whether infection-preventing bone graft treatment can improve outcomes after surgery.

04 Bacterial Infections and Surgical Procedures

Research in bacterial infections and surgical procedures is centered on preventing post-operative complications and improving the success of orthopedic treatment.

  • Prevention of infection in bone graft use
  • Protection against bacteria-related complications after surgery
  • Testing a treatment approach designed to support surgical recovery

These trials help clarify whether infection-focused interventions can make operative care safer and more effective.

05 Musculoskeletal and Neural Physiological Phenomena

The local research profile also reflects interest in musculoskeletal and neural physiological phenomena, with clinical studies examining how the body responds to allergy treatment and orthopedic interventions.

  • Changes in symptoms and function over time
  • Patient response after allergen treatment
  • Recovery patterns following joint replacement

In Trelleborg, these studies aim to connect physiological changes with practical benefits for patients.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.